Overweight

Showing NaN - NaN of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)

Recruiting
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +31 more
Apr 26, 2023

Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +21 more
Jan 24, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Implementation ofCardiometabolic Disease Staging System in

Completed
  • Diabetes
  • +2 more
  • Clinical decision support system
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 18, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +4 more
  • Lifestyle Intervention
  • Birmingham, Alabama
  • +38 more
Mar 10, 2022

Overweight, Obesity Trial in Birmingham (Energy Reduction)

Active, not recruiting
  • Overweight
  • Obesity
  • Energy Reduction
  • Birmingham, Alabama
    University of Alabama at Birmingham, Medical Towers Building
Mar 23, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Mar 21, 2022

Obesity, Overweight Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Overweight
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +50 more
Jan 26, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Nov 10, 2021

Weight Loss, Overweight, Obesity Trial in United States

Recruiting
  • Weight Loss
  • +2 more
    • Birmingham, Alabama
    • +6 more
    Jul 20, 2021

    Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)

    Unknown status
    • Overweight
    • +3 more
    • Gelesis200
    • Placebo
    • Birmingham, Alabama
    • +29 more
    Jul 20, 2020

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

    Terminated
    • Obesity
    • Overweight
    • Birmingham, Alabama
    • +223 more
    Feb 24, 2017

    Sedentary, Overweight Trial in Birmingham (Exercise)

    Unknown status
    • Sedentary
    • Overweight
    • Exercise
    • Birmingham, United Kingdom
      University of Birmingham, School of Sport, Exercise and Rehabili
    Oct 27, 2016

    Breast Cancer, Overweight, Obesity Trial in United States (Less Intensive, Intensive Group)

    Completed
    • Breast Cancer
    • +2 more
    • Less Intensive
    • Intensive Group
    • Birmingham, Alabama
    • +3 more
    Jun 17, 2015

    Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

    Completed
    • Overweight
    • Obesity
    • pramlintide acetate
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Mar 26, 2015

    Overweight, Obesity Trial in United States (pramlintide acetate, sibutramine, phentermine)

    Completed
    • Overweight
    • Obesity
    • pramlintide acetate
    • +3 more
    • Birmingham, Alabama
    • +15 more
    Mar 5, 2015

    Obesity, Overweight Trial in United States (AC2307, )

    Completed
    • Obesity
    • Overweight
    • Birmingham, Alabama
    • +17 more
    Jan 16, 2015

    Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

    Completed
    • Obesity
    • Overweight
    • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
    • +3 more
    • Birmingham, Alabama
    • +33 more
    Nov 18, 2014

    Type 2 Diabetes, Overweight, Obesity Trial in United States (Weight Watchers modified program, Standard Care group)

    Completed
    • Type 2 Diabetes
    • +2 more
    • Weight Watchers modified program
    • Standard Care group
    • Birmingham, Alabama
    • +14 more
    Oct 14, 2014

    Obesity, Body Weight, Weight Loss Trial in Birmingham (Food-based, Reduced Energy Diet Plan, Medifast 5 & 1 Plan)

    Completed
    • Obesity
    • +4 more
    • Food-based, Reduced Energy Diet Plan
    • Medifast 5 & 1 Plan
    • Birmingham, Alabama
      University of Alabama at Birmingham Division of Preventive Medic
    Jun 17, 2013

    Obesity, Overweight, Weight Loss Trial in Birmingham (Extra sugar-free chewing gum sticks, nutrition brochure)

    Completed
    • Obesity
    • +2 more
    • Extra sugar-free chewing gum sticks
    • nutrition brochure
    • Birmingham, Alabama
      University of Alabama at Birmingham Division of Preventive Medic
    Nov 22, 2010